As of Feb 17
| +0.47 / +0.61%|
The 28 analysts offering 12-month price forecasts for Novartis have a median target of 80.34, with a high estimate of 92.00 and a low estimate of 70.09. The median estimate represents a +4.07% increase from the last price of 77.20.
The current consensus among 31 polled investment analysts is to Hold stock in Novartis. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.